Latest Trials

Systemic therapy trial

Xcovery XALT3 : Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic...

This phase III trial is evaluating the safety and efficacy of X-396 (ensartinib), compared to crizitonib, in patients with ALK+ Non-Small Cell (NSC) lung cancer

Status : Recruiting

Systemic therapy trial

MEDI4736 : A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab Versus...

This phase III trial is evaluating the safety of an immunotherapy drug (Durvalumab) and platinum based SoC chemotherapy as a first line treatment for patients with Non-Small Cell (NSC) Lung Cancer

Status : Recruiting

Systemic therapy trial

APROC : A phase1b/2 Study Evaluating the Efficacy of APR-246, a First-in-class Agent Targeting...

This phase Ib/II trial is trying to determine whether the drug APR-246 and two chemotherapy drugs (5-FU and cisplatin) are safe and effective in the treatment of platinum resistant oesophageal cancer

Status : Recruiting

Systemic therapy trial

DREAM : A phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a...

This phase II trial is combining a drug (durvalumab) and first line chemotherapy for the treatment of mesothelioma

Status : Recruiting

Systemic therapy trial

CT883 : A Multistage, Phase II Study Evaluating the Safety and Efficacy of Cobimetinib Plus...

This phase II trial is evaluating Cobimetinib (a chemotherapy agent), in combination with three drugs (Paclitaxel, Atezolizumab and Nab-Paclitaxel), as a first line treatment for Triple Negative Breast Cancer that has spread to other parts of the body

Status : Recruiting

Systemic therapy trial

CT882 : A Phase 3 Randomized, Open-label, Multicenter Study Comparing Isatuximab (SAR650984) in...

This phase III trial is trying to demonstrate the benefit of adding isatuximab to pomalidomide and dexamethasone treatment in patients with Multiple Myeloma

Status : Recruiting

Systemic therapy trial

AMaRC 03-16 : A Randomised phase 2 study of bortezomib, cyclophosphamide and dexamethasone induction...

This phase II trial is assessing an induction therapy (VCD) alone and with daratumumab maintenance (VCDD) as a treatment alternative for Multiple Myeloma patients who are unable to receive a transplant

Status : Not yet recruiting

Systemic therapy trial

IMvigor130 : A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab...

This phase III trial is evaluating atezolizumab and chemotherapy for patients with previously untreated, advanced urothelial cancer

Status : Recruiting

Systemic therapy trial

OZM-054 : A Phase II, Randomized, Multi-center Study of Cabazitaxel Versus Abiraterone or...

This phase II trial is comparing Cabazitaxel (a chemotherapy drug) with Abiraterone (a new type of hormone therapy) and Enzalutamide (an oral drug) for the treatment of castration-resistant prostate cancers that express poor outcomes

Status : Recruiting

Systemic therapy trial

KEYNOTE-240 : A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as...

This phase III trial is evaluating pembrolizumab in patients who have previously received systemic treatment for advanced hepatocellular (liver) cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.